Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 126,263 | 36,112 | 80,386 | 61,661 | 46,600 |
| Marketable Securities | 26,012 | 235,547 | 79,666 | 249,127 | 299,904 |
| Receivables | 395 | 56,532 | 5,924 | 4,825 | 7,492 |
| Inventories | N/A | 4,243 | 4,680 | 1,948 | N/A |
| TOTAL | $157,719 | $337,754 | $173,324 | $321,995 | $357,874 |
| Non-Current Assets | |||||
| PPE Net | 295 | 14,047 | 15,865 | 17,687 | 19,390 |
| Intangibles | 44,543 | 64,259 | 94,662 | 96,428 | 97,900 |
| Other Non-Current Assets | 1,231 | 1,655 | 285 | 429 | 461 |
| TOTAL | $46,069 | $79,961 | $110,812 | $114,544 | $117,751 |
| Total Assets | $203,788 | $417,715 | $284,136 | $436,539 | $475,625 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,646 | 11,012 | 1,115 | 14,094 | 16,280 |
| Accounts payable and accrued liabilities | 5,469 | 12,178 | 12,052 | 38,762 | 52,877 |
| Accrued Expenses | 29,691 | 42,151 | 21,245 | 12,282 | 32,114 |
| TOTAL | $46,806 | $65,341 | $36,751 | $105,489 | $164,643 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 234,171 | 243,887 | 231,576 | 85,167 |
| Deferred Revenues | N/A | N/A | 2,339 | 40,351 | 63,372 |
| Other Non-Current Liabilities | 611 | 1,102 | 238 | 292 | 805 |
| TOTAL | $611 | $235,273 | $273,790 | $262,785 | $153,581 |
| Total Liabilities | $47,417 | $300,614 | $310,541 | $368,274 | $318,224 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,354 | 106,970 | 106,272 | 105,592 | 104,320 |
| Common Shares | 142 | 106 | 106 | 106 | 105 |
| Retained earnings | -1,400,018 | -1,341,444 | -1,471,577 | -1,365,241 | -1,250,363 |
| Other shareholders' equity | 151 | 267 | 112 | -126 | -563 |
| TOTAL | $156,371 | $117,101 | $-26,405 | $68,265 | $157,401 |
| Total Liabilities And Equity | $203,788 | $417,715 | $284,136 | $436,539 | $475,625 |